Literature DB >> 5388626

[Pharmacological studies on the root bark of paeonia moutan. I. Central effects of paeonol].

M Harada, A Yamashita.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5388626     DOI: 10.1248/yakushi1947.89.9_1205

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


× No keyword cloud information.
  5 in total

1.  Exploring targets and signaling pathways of paeonol involved in relieving inflammation based on modern technology.

Authors:  Jian-Hong Qi; Fang-Xu Dong; Xiao-Long Wang
Journal:  Mol Divers       Date:  2021-08-31       Impact factor: 3.364

2.  Inhibitory effects of 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose on biofilm formation by Staphylococcus aureus.

Authors:  Mei-Hui Lin; Fang-Rong Chang; Mu-Yi Hua; Yang-Chang Wu; Shih-Tung Liu
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.938

3.  5-Episinuleptolide Decreases the Expression of the Extracellular Matrix in Early Biofilm Formation of Multi-Drug Resistant Acinetobacter baumannii.

Authors:  Sung-Pin Tseng; Wei-Chun Hung; Chiung-Yao Huang; Yin-Shiou Lin; Min-Yu Chan; Po-Liang Lu; Lin Lin; Jyh-Horng Sheu
Journal:  Mar Drugs       Date:  2016-07-29       Impact factor: 5.118

4.  Paeonol Ameliorates Chronic Itch and Spinal Astrocytic Activation via CXCR3 in an Experimental Dry Skin Model in Mice.

Authors:  Wen Wang; Qiaoyun Li; Zhongqiu Zhao; Yutong Liu; Yi Wang; Hui Xiong; Zhinan Mei
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

5.  Paeonol Ameliorates Diabetic Renal Fibrosis Through Promoting the Activation of the Nrf2/ARE Pathway via Up-Regulating Sirt1.

Authors:  Lei Zhang; Zhiquan Chen; Wenyan Gong; Yezi Zou; Futian Xu; Lihao Chen; Heqing Huang
Journal:  Front Pharmacol       Date:  2018-05-18       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.